Vial
San Francisco, United States · Founded 2020 · $34.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- vial.com
- Total Funding
- $34.0M
- Last Round
- $34.0M Series BNov 2022
- Rounds
- 5
About
Next-generation pharma company using computationally designed therapeutics and automated clinical trials to advance RNA, antibody, and small-molecule programs.
Summary
Vial is a Life Sciences company based in San Francisco, United States, founded in 2020. It has raised $34.0M in total across 5 rounds, most recently a $34.0M Series B round in Nov 2022. Investors include Buckley Ventures, General Catalyst and Andreessen Horowitz.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...